Studienserver - Medizinische Hochschule Hannover

Studien: Panobinostat (LBH589) in Kombination mit Idarubicin und Cytarabin

ID Studie

CLBH589G2101

EudraCT-Nummer

2009-016809-42

Clinicaltrials.gov Identifier

NCT01242774

Beschreibung

A phase Ib, dose-finding study of oral panobinostat (LBH589) in combination with idarubicin and cytarabine induction and high-dose cytarabine-based consolidation therapy in adult patients less than or equal to 65 years old with acute myeloid leukemia (AML)

Status

gestoppt